Výsledky vyhledávání
- 1.CHRASTINOVÁ, L.G; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; CEZNEROVÁ, E.; KOTLÍN, R.; PECHERKOVÁ, P.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; HAVLÍČEK, M.; VÁLKA, J.; HOMOLA , J.; SUTTNAR, J. Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array. Scientific reports. 2023, vol. 13, no. 1, art. no. 12816. ISSN 2045-2322.
- 2.SKORNOVA, I.; SIMURDA, T.; STANCIAKOVA, L.; LAUKO, V.; HOLLY, P.; SAMOS, M.; BOLEK, T.; SCHNIERER, M.; DROTAROVA, M.; BELAKOVA, K.M.; SOKOL, J.; STASKO, J.; MOKAN, M.; GUMULEC, J.; CHRASTINOVA, L. A functional assay for the determination of heparin-induced thrombocytopenia via flow cytometry. Diagnostics. 2023, vol. 13, no. 18, art. no. 3019. ISSN 2075-4418.
- 3.HLAVACKOVA, A.; VYDRA, J.; KOVAROVA, H.; CHRASTINOVA, L.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Significant differences of serum metabolism in acute myeloid leukemia WITH IDH2 mutations. [Prezentováno: EHA-SWG scientific meeting on MDS/MPN/AML: commonalities and differences of myeloid neoplasms. Budapest, 2.11.-4.11.2023.].
- 4.BOCKOVÁ, M.; ŠPRINGER, T.; CHRASTINOVÁ, L.; KREJČÍK, Z.; SUTTNAR, J.; HOMOLA, J. Advances in plasmonic biosensors and their applications in oncohematology. [Prezentováno: Czech Annual Cancer Research Meeting. Olomouc, 1.12.-2.12.2022.].
- 5.CHRASTINOVÁ, L.; PASTVA, O.; BOCKOVÁ, M.; KOVÁŘOVÁ, H.; ŠTIKAROVÁ, J.; HLAVÁČKOVÁ, A.; VÁLKA, J.; HOMOLA J.; SUTTNAR, J. Aberrant glycosylation patterns in myelodysplastic syndrome: a lectin array study. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 6.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; KOVAROVA, H.; STIKAROVA, J.; SUTTNAR, J. Targeted metabolomic profiling of AML patients: the effect of conditioning regimens on post-transplantation complications. [Prezentováno: EHA-SWG scientific meeting on integrated cell tracking in oncohematology: diagnosis, targeted therapy and residual disease. Bordeaux, 10.11.-12.11.2022.].
- 7.CEZNEROVÁ, E.G; KAUFMANOVÁ, J.; ŠTIKAROVÁ, J.; PASTVA, O.; LOUŽIL, J.; CHRASTINOVÁ, L.; SUTTNAR, J.; KOTLÍN, R.; DYR, J.E. Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications. Blood coagulation & fibrinolysis. 2022, vol. 33, no. 4, s. 228-237. ISSN 0957-5235.
- 8.HLAVACKOVA, A.; VYDRA, J.; CHRASTINOVA, L.; CEZNEROVA, E.; HAVLICEK, M.; STIKAROVA, J.; KOTLIN, R.; SUTTNAR, J. Metabolic alterations and elevation of oxidative stress during the early post-transplant period in AML patients. Blood. 2022, vol. 140, no. S1, s. 11833. ISSN 0006-4971.
- 9.PASTVA, O.; CHRASTINOVÁ, L.; BELIČKOVÁ, M.; PIMKOVÁ, K.; SUTTNAR, J. Proteostasis mapping in myelodysplastic syndrome by aberrant subproteome of blood plasma. [Prezentováno: II. český hematologický a transfuziologický sjezd. Olomouc, 12.9.-15.9.2021.].
- 10.CHRASTINOVÁ, L.; PASTVA, O.; BOCKOVÁ, M.; KOČÍ, H.; PECHERKOVÁ, P.; HOMOLA, J.; ČERMÁK, J.; SUTTNAR, J. Monitoring of myelodysplastic syndrome progression based on lectin array and surface plasmon resonance sensor. [Prezentováno: II. český hematologický a transfuziologický sjezd. Olomouc, 12.9.-15.9.2021.].